David I. Rosenthal MD, FASTRO, FACR

David I. Rosenthal, MD is a Professor of Radiation Oncology and Head & Neck Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas. He is a Fellow of the American College of Radiology (FACR), the American Society for Radiation Oncology (FASTRO), and the American Head & Neck Society (AHNS).

He is focused on developing new methods to improve survival and functional outcomes, and techniques to reduce side-effects and toxicities from Head & Neck cancer treatment. These include proton therapy, IMRT, VMAT, SBRT, drug development, immunotherapy, acute and late toxicity evaluation (including mucositis, dermatitis, dysphagia, and xerostomia), their management, prevention, patient reported outcomes, and quality and safety research. He serves as principal investigator for numerous national cooperative group and institutional clinical trials; has >200 related peer-reviewed publications, and is co-editor of a textbook: Head and Neck Cancers: Evidence-Based Treatment

Dr. Rosenthal is actively involved with the education and training of residents and fellows in radiation oncology. He is a sub-specialist expert in head and neck radiation oncology, and serves as Chief of the MD Anderson Head & Neck Radiation Oncology Service that represents greater than a century of Head & Neck physician cancer expertise by nine radiation oncology physicians, and a specialized team of radiotherapy physician assistants, nurses, physicists, therapists, and dosimetrists. Dr. Rosenthal and his team treat all types of Head & Neck and skin cancers, and work closely with colleagues from other related specialties to derive personalized treatment plans for each individual patient.